Aspen Pharmacare Cash on Hand 2017-2023 | APNHY

Aspen Pharmacare cash on hand from 2017 to 2023. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Aspen Pharmacare cash on hand for the quarter ending June 30, 2023 was $0.615B, a 2.11% decline year-over-year.
  • Aspen Pharmacare cash on hand for 2023 was $0.615B, a 51.27% increase from 2022.
  • Aspen Pharmacare cash on hand for 2022 was $0.407B, a 26.98% decline from 2021.
  • Aspen Pharmacare cash on hand for 2021 was $0.557B, a 21.98% increase from 2020.
Aspen Pharmacare Annual Cash on Hand
(Millions of US $)
2023 $615
2022 $407
2021 $557
2020 $457
2019 $633
2018 $872
2017 $786
2016 $756
2015 $
Aspen Pharmacare Quarterly Cash on Hand
(Millions of US $)
2023-06-30 $615
2022-06-30 $407
2021-12-31 $512
2021-06-30 $557
2020-12-31 $629
2020-06-30 $457
2019-06-30 $633
2018-12-31 $690
2018-06-30 $872
2017-12-31 $625
2017-06-30 $786
2016-12-31 $682
2016-06-30 $756
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $5.328B $2.296B
Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $15.751B 5.69
Dr Reddy's Laboratories (RDY) India $12.261B 19.39
BridgeBio Pharma (BBIO) United States $4.794B 0.00
Bausch Health Cos (BHC) Canada $3.201B 2.50
Amphastar Pharmaceuticals (AMPH) United States $2.016B 13.80
Supernus Pharmaceuticals (SUPN) United States $1.655B 0.00
Taysha Gene Therapies (TSHA) United States $0.454B 0.00
Generation Bio (GBIO) United States $0.188B 0.00
Personalis (PSNL) United States $0.074B 0.00
Assembly Biosciences (ASMB) United States $0.068B 0.00
Acasti Pharma (ACST) Canada $0.026B 0.00
Sol-Gel Technologies (SLGL) Israel $0.020B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00